Works matching IS 0012186X AND DT 2021 AND VI 64 AND IP 6


Results: 33
    1

    Up front.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1187, doi. 10.1007/s00125-021-05462-y
    Publication type:
    Article
    2
    3
    4
    5
    7

    The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1358, doi. 10.1007/s00125-021-05435-1
    By:
    • Gerst, Felicia;
    • Kemter, Elisabeth;
    • Lorza-Gil, Estela;
    • Kaiser, Gabriele;
    • Fritz, Ann-Kathrin;
    • Nano, Rita;
    • Piemonti, Lorenzo;
    • Gauder, Marie;
    • Dahl, Andreas;
    • Nadalin, Silvio;
    • Königsrainer, Alfred;
    • Fend, Falko;
    • Birkenfeld, Andreas L.;
    • Wagner, Robert;
    • Heni, Martin;
    • Stefan, Norbert;
    • Wolf, Eckhard;
    • Häring, Hans-Ulrich;
    • Ullrich, Susanne
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1320, doi. 10.1007/s00125-021-05413-7
    By:
    • Jeyam, Anita;
    • Gibb, Fraser W.;
    • McKnight, John A.;
    • Kennon, Brian;
    • O'Reilly, Joseph E.;
    • Caparrotta, Thomas M.;
    • Höhn, Andreas;
    • McGurnaghan, Stuart J.;
    • Blackbourn, Luke A. K.;
    • Hatam, Sara;
    • McCrimmon, Rory J.;
    • Leese, Graham;
    • Lindsay, Robert S.;
    • Petrie, John;
    • Chalmers, John;
    • Philip, Sam;
    • Wild, Sarah H.;
    • Sattar, Naveed;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1279, doi. 10.1007/s00125-021-05401-x
    By:
    • Chen, Yanyan;
    • Zhang, Ping;
    • Wang, Jinping;
    • Gong, Qiuhong;
    • An, Yali;
    • Qian, Xin;
    • Zhang, Bo;
    • Li, Hui;
    • Gregg, Edward W.;
    • Bennett, Peter H.;
    • Li, Guangwei
    Publication type:
    Article
    29
    30

    The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1226, doi. 10.1007/s00125-021-05399-2
    By:
    • O'Donoghue, Michelle L.;
    • Kato, Eri T.;
    • Mosenzon, Ofri;
    • Murphy, Sabina A.;
    • Cahn, Avivit;
    • Herrera, Marisol;
    • Tankova, Tsvetalina;
    • Šmahelová, Alena;
    • Merlini, Piera;
    • Gause-Nilsson, Ingrid;
    • Langkilde, Anna Maria;
    • McGuire, Darren K.;
    • Wilding, John P. H.;
    • Leiter, Larry A.;
    • Bhatt, Deepak L.;
    • Raz, Itamar;
    • Sabatine, Marc S.;
    • Wiviott, Stephen D.
    Publication type:
    Article
    31
    32
    33

    The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1309, doi. 10.1007/s00125-021-05394-7
    By:
    • Höhn, Andreas;
    • Jeyam, Anita;
    • Caparrotta, Thomas M.;
    • McGurnaghan, Stuart J.;
    • O'Reilly, Joseph E.;
    • Blackbourn, Luke A. K.;
    • McCrimmon, Rory J.;
    • Leese, Graham P.;
    • McKnight, John A.;
    • Kennon, Brian;
    • Lindsay, Robert S.;
    • Sattar, Naveed;
    • Wild, Sarah H.;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article